Preparation of different fragments of SARS-CoV-2 N protein and its application in fluorescence chromatography.
- Author:
Dengzhou LI
1
;
Yunlong WANG
2
;
Yiqing ZHANG
2
;
Jichuang WANG
2
;
Yao LU
2
;
Guo LI
3
;
Yongwei LI
1
;
Yulin LI
2
;
Heng ZHANG
4
;
Xiaojun WANG
4
Author Information
- Publication Type:Journal Article
- Keywords: SARS-CoV-2; antibody detection; fluorescence immunechromatography; nucleocapsid protein
- MeSH: Antibodies, Viral; COVID-19; Chromatography, Affinity; Fluorescent Antibody Technique; Humans; Microspheres; SARS-CoV-2; Sensitivity and Specificity
- From: Chinese Journal of Biotechnology 2021;37(11):4066-4074
- CountryChina
- Language:Chinese
- Abstract: Different fragments of SARS-CoV-2 nucleocapsid (N) protein were expressed and purified, and a fluorescence immunochromatography method for detection of SARS-CoV-2 total antibody was established. The effect of different protein fragments on the performance of the method was evaluated. The N protein sequence was analyzed by bioinformatics technology, expressed in prokaryotic cell and purified by metal ion affinity chromatography column. Different N protein fragments were prepared for comparison. EDC reaction was used to label fluorescence microsphere on the synthesized antigen to construct sandwich fluorescence chromatography antibody detection assay, and the performance was systemically evaluated. Among the 4 prepared N protein fragments, the full-length N protein (N419) was selected as the optimized coating antigen, N412 with 0.5 mol/L NaCl was used as the optimal combination; deleting 91-120 amino acids from the N-terminal of N412 reduced non-specific signal by 87.5%. the linear range of detection was 0.312-80 U/L, the limit of detection was 0.165 U/L, and the accuracy was more than 95%. A fluorescence immunochromatographic detection method for analysis of SARS-CoV-2 total antibody was established by pairing N protein fragments. The detection result achieved 98% concordance with the commercially available Guangzhou Wanfu test strip, which is expected to be used as a supplementary approach for detection of SARS-CoV-2. The assay could also provide experimental reference for improving the performance of COVID-19 antibody detection reagents.